Skip to main content

Table 7 Patient satisfaction with study pen device, n (%)

From: Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)

Characteristic Ovaleap® (n = 151) Gonal-f® (n = 142)
Confidence about accurate dose   
 Very confident 123 (81.5) 112 (78.9)
 Confident 28 (18.5) 30 (21.1)
Confidence about correct injection   
 Very confident 115 (76.2) 110 (77.5)
 Confident 34 (22.5) 32 (22.5)
 Not confident 1 (0.7) 0 (0)
Plainness of instructional text   
 Very easy 113 (74.8) 100 (70.4)
 Easy 38 (25.2) 42 (29.6)
Frequency of need for explanation of administration   
 Never 85 (56.3) 67 (47.2)
 Once 57 (37.7) 69 (48.6)
 Twice 7 (4.6) 2 (1.4)
 Three times 0 (0) 1 (0.7)
Convenience of pen usage   
 Very convenient 117 (77.5) 107 (75.4)
 Convenient 34 (22.5) 35 (24.6)
Satisfaction with administration   
 Very satisfied 116 (76.8) 108 (76.1)
 Satisfied 35 (23.2) 34 (23.9)